Phenotypic Properties in Individuals Affected With XLHED

NCT01871714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2013-11-27

No results posted yet for this study

Summary

The current study design incorporates two previously developed, non-invasive approaches to characterize the phenotype of individuals affected with XLHED.

Conditions

  • X Linked Hypohidrotic Ectodermal Dysplasia

Sponsors & Collaborators

  • Edimer Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Dorothy K Grange, MD · Washington University School of Medicine

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-07-31
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01871714 on ClinicalTrials.gov